Menu
Home
Products
Specialties
Services
Contact Janssen
Choose your language
English
EN
English
EN
Menu
Products
Specialties
Services
Contact Janssen
Choose your language
English
EN
English
EN
This year on EHA, we shared exciting new data on Imbruvica
®
(ibrutinib) in RESONATE-2
Media Center
Watch professor Ghia reveal how results from up to 7 years of follow-up reinforce the ground-breaking advance in 1L CLL that Imbruvica represents.
[1]
Categories / tags
Imbruvica
See all related
CP-240988 - June 2021